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Abstract. 
This paper describes a method to detect the presence of bacteria in aqueous samples, based 
on the capture of bacteria on a syringe filter, and the infection of targeted bacterial species with a 
bacteriophage (phage). The use of phage as a reagent provides two opportunities for signal 
amplification: i) the replication of phage inside a live bacterial host (1000-fold amplification for 
M13 phage in E. coli K12), and ii) the rapid conversion of a colorless substrate to a colored or 
fluorescent product by an enzyme that is co-expressed with the phage (in this demonstration β-
galactosidase, which has a turnover rate of ~ 600 molecules/second).  This method can detect a 
single colony-forming unit (CFU) of E. coli in one liter of water with an overnight culture-based 
assay, or 50 CFUs of E. coli in 1 liter of water (or 10 mL of orange juice, or 10 mL of skim milk) 
in less than four hours with a solution-based assay with visual readout. The solution-based assay 
does not require specialized equipment or access to a laboratory, and is more rapid than existing 
tests that are suitable for use at the point of access. This method could be applied to the detection 
of many different bacteria, in parallel, with bacteriophages that express enzymes not natively 
expressed in the target bacteria.   
 
Introduction. 
  The guidelines for monitoring bacterial contamination in a public supply of water, or in a 
supply of food, are stringent to mitigate threats to public health. Analytical methods approved by 
the Environmental Protection Agency (EPA) must ensure that a public water supply maintains 
fewer than one colony-forming unit (CFU) of coliform bacteria in 100 mL of water,
1 and the 
Food and Drug Administration (FDA) has a “zero tolerance” policy for the presence of bacterial 
species such as E. coli O157:H7, Salmonella sp., and Listeria monocytogenes in foodstuffs.
2,3  
  The detection of such small numbers of bacteria requires an amplification step: EPA-
approved methods rely on microbiological culture, affinity capture (based on antibodies),
4,5 or 
the amplification of nucleic acids.
3,6 Microbiological cultures determine the number of live 
bacteria in a sample, but require incubation periods ranging from several hours to several days at 
temperatures between 30 - 45 
oC;
7,8 the “rapid” test for coliform bacteria approved by the EPA 
requires a 16-hour incubation at 35 
oC. Nucleic acid-based methods such as multiplexed PCR 
can determine the identity and number of bacteria present in a sample
9,10 within a period of 2 - 8 
hours, but are more difficult and costly to run than cultures because they require access to 
laboratory equipment and reagents. There are a number of lab-on-chip
11,12 and paper-based
13,14 
prototypes, but none have yet provided a simple analytical method that meets the approval of the 
EPA. Several commercial products are also available to detect coliform bacteria in a sample of 
water, at the point of access, but these products are culture-based, and require incubation periods 
of 12 hours or longer. 
  Bacteriophages (phages) are viruses that selectively infect a bacterial host, and utilize the 
cellular machinery of the host to replicate in number. Phages are well-suited as a reagent for 
detecting the presence of bacteria in a sample, because they: i) amplify in number naturally, once  
 
they have infected the targeted host; ii) are species- or serotype-specific,
15,16 and this specificity 
reduces the probability of a false-positive result; iii) require a single reagent, the phage of 
interest; iv) can be produced in large numbers at a low cost; v) can be stored for long periods in a 
dry state;
17,18 vi) pose no threats to humans, and can be handled without fear of infection or 
illness;
16,19 and, vii) can be engineered to co-express enzymes or peptide sequences that are not 
natively expressed in the targeted bacteria. 
  Existing phage-based assays for the detection of E. coli utilize a single amplification step and 
detection by microscopy or cell sorting.
18,20,21 The phages are pre-labeled with a fluorophore, or 
engineered to display a specific peptide sequence (e.g., a biotinylated peptide,
20 or a tetra-
cysteine peptide motif
21) that is recognized by a peptide-specific fluorophore. 
  A point-of-access assay for bacteria that combines the simplicity of culture with the short 
time periods required for nucleic acid-based methods is not currently available. We describe a 
simple, portable, filter-based assay that can to detect fewer than 50 CFUs of E. coli in one liter of 
liquid in 4 hours by exploiting two different types of selective signal amplification: i) the 
replication of phage within live bacteria, and ii) the production of hundreds (or thousands) of 
colored or fluorescent molecules per second from an enzymatic reaction (Scheme 1). We use this 
bacteriophage-based method to identify E. coli present in samples of drinking water, milk, and 
orange juice. 
Experimental Design. 
Choice of bacterial species and liquid samples. We chose E. coli K12 (ER2378) as a model 
organism for the phage-based assay because: i) it is a coliform bacterium, which is a rod-shaped 
bacterium that is not necessarily pathogenic but may be indicative of pathogenic bacteria 
associated with fecal matter, and thus a target organism for EPA-approved methods; ii) it is  
 
engineered to not express β-galactosidase (βgal); and, iii) there is a commercially available, βgal-
expressing bacteriophage.  
We detected and quantified the number of CFUs of E. coli in drinking water, drinking water 
contaminated with particulates of soil (5 g / 100 mL; i.e., “dirty water”), skim milk, and pulp-
free orange juice. We chose to test samples of water because a significant number (15%) of 
Americans,
22,23 and a larger proportion of people in the developing world, obtain drinking water 
from private sources (e.g., a well, cistern, or stream) that are not monitored unless an outbreak of 
water-borne disease has occurred. We selected milk and orange juice because they are 
commodity foodstuffs, and require constant monitoring; there is currently no diagnostic capable 
of detecting the presence of bacteria in a sample of milk at the site of milk collection and 
processing. The collection and pooling of milk samples in the developing world, or other locales 
where pasteurization is not feasible, may result in a single sample of bacteria-containing milk 
contaminating an entire pool.
24 Milk and orange juice also pose analytical challenges because 
they are opaque, and not compatible with assays based on a visual readout. 
Choice of bacteriophage. We chose an M13 phage that co-expresses a single copy of βgal 
with each phage. A single bacterium infected by M13 phage produces an average burst size of 
1000 plaque-forming units (PFUs) of phage within an hour of infection.25,26 The choice of a βgal-
expressing phage is advantageous, because: i) the enzymatic turnover of βgal (e.g., 620 
molecules sec
-1 at pH = 7.0 and 20 
oC)
27 provides a second stage of amplification, and ii) the 
products of the enzymatic assay can be detected visually, and eliminate the need for culture steps 
(or a plaque assay). 
Concentration and amplification of E. coli using a syringe filter. We began every assay by 
filtering the sample through a 0.2-µm syringe filter to capture the bacteria from the sample  
 
(Scheme 1). These filters are available in pre-packaged sterile units, and represent a self-
contained microbiology laboratory in which the captured bacteria can be incubated and handled 
without fear of contamination. The filters retain the bacteria throughout multiple washing steps, 
which are necessary to reduce colored contaminants or excess salts from samples such as milk or 
orange juice that may interfere with detection, but allow for the elution and collection of newly 
produced phage and βgal following incubation. 
Indirect detection of E. coli with phage- and βgal-based assays. The quantity of phage (or 
βgal) collected after incubation correlates with the number of viable bacteria captured on the 
syringe filter because bacteriophages can only replicate in a live bacterial host. To validate this 
correlation, we quantified the newly produced phages with a plaque assay,
18 a standard 
microbiological assay in which the phage are introduced to solid agar containing E. coli, and 
plaques (regions of dead bacteria) are counted after incubation. The M13-phage-infected bacteria 
produce blue-colored plaques in the presence of a colorimetric substrate for βgal: 5-bromo-4-
chloro-3-indolyl β-D-galactopyranoside, Xgal.  
For the portable assay, we detected the captured E. coli with a solution-based assay that relies 
on the enzymatic activity of βgal to produce a colorimetric or fluorescent product. A readout 
based on the production of a fluorescent molecule is desirable because the limit of detection of a 
fluorescent signal is much lower than that of a colorimetric signal, and fluorescence readings are 
less susceptible to interferences from colored solutions. 
Results and Discussion. 
Filtration of liquids through the syringe filter improves the detection of colored products. 
The background absorption and/or scattering of light by opaque or colored samples make the 
detection of a colorimetric product difficult. We prepared samples of drinking water, orange  
 
juice, skim milk, and dirty water with increasing concentrations of chlorophenol red—one 
possible product of the βgal assay—ranging from 4 µM to 250 µM (Figure 1a). The red color of 
chlorophenol red can be observed at a concentration of 8 µM in drinking water, but is more 
difficult to detect in orange juice (125 µM), milk (63 µM), and dirty water (16 µM). 
Figure 1b shows samples of orange juice, milk, and dirty water before and after filtration. 
The increased transparency of the samples after filtration facilitates the detection of a colored or 
fluorescent molecule. Figure 1c compares the transmittance (λ = 570 nm, the maximum 
absorption of chlorophenol red) of the liquid samples in Figure 1b before and after filtration. 
Samples of orange juice and dirty water passed easily through the 0.2-µm filter, but less than 
1 mL of skim milk clogged the filter. We found that adding a sodium hydroxide (to a final 
concentration of 0.4% w/v) to the samples of milk greatly reduced their viscosity, and allowed 
them to pass through the filter. Basic solutions are known to be anti-bacterial, but short 
exposures are not lethal.
28 
Filtration of liquids through the syringe filter captures and retains bacteria. To ensure the 
bacteria contained in a liquid sample were captured (and retained) during filtration and several 
washing steps, we filtered 5-mL samples of drinking water, orange juice, skim milk, and dirty 
water containing 5000 CFUs of a βgal-expressing E. coli (NCTC 9001) and rinsed each sample 
with 10 mL of 1X phosphate buffered saline (1X PBS). We then centrifuged the filtrates at 
14000 x g for 10 minutes, removed the supernatant, resuspended the pellet with 1 mL of 1X 
PBS, and plated it on an agar plate containing Xgal. We included several positive controls 
(containing 5, 50, and 500 CFUs of E. coli NCTC 9001), which we suspended in 10 mL of 1X 
PBS, centrifuged, and plated. The positive control samples each contained blue-colored plaques,  
 
while the filtrates contained no plaques (n = 3 samples of each liquid); these results show that the 
syringes effectively capture bacteria from the sample, and sterilize the filtrate.  
We performed a separate set of controls to determine if the viability of E. coli in a sample of 
milk decreased when exposed to sodium hydroxide (0.4 % w/v); we found that exposures within 
the time required to add sodium hydroxide to a sample of milk, filter the sample, and rinse it with 
1X PBS (~15 minutes) did not decrease the viability of 5 CFUs of E. coli in the sample (see 
Supporting Information). 
A culture-based readout has a limit of detection of one CFU of E. coli in one liter of 
drinking water. We determined the limit of detection of the phage-based assay with an overnight 
culture-based readout (i.e., a “plaque assay”) for samples containing between zero and 5000 
CFUs of E. coli K12. Because the plaque assay cannot distinguish between newly produced 
phage and excess phage remaining on the filter, we inactivated the excess phage by rinsing the 
filter with a solution of ferrous ammonium sulfate,
29 followed by a solution of sodium citrate to 
chelate and remove excess ferrous ions (Scheme 1, see Supporting Information for experimental 
details). We incubated the syringe filters for an additional 60 minutes to allow the phages to 
complete their replication cycle prior passing one mL of 1X PBS through the filter, and applying 
the solutions to a plate of solid agar containing E. coli and Xgal (detailed procedure in 
Supporting Information). We counted the number of plaque-forming units (PFUs) after a 12-hour 
incubation, and plotted the number of PFUs as a function of CFUs of E. coli captured on the 
filter (Figure 2a). The number of PFUs detected in the plaque assay for large number of E. coli 
is less than expected, based on the average burst of an M13 phage of 1000.
25,30 Early work on 
phage supports the relationship between phage concentration and plaque count that we 
observed.
18,31  
 
Samples of drinking water containing a single CFU of E. coli produced 310 ± 30 PFUs; this 
value is well above the LOD, which we calculated from the background noise (20 ± 30 PFUs) of 
samples containing zero E. coli. Both the LOD of the culture-based readout and the average 
number of PFUs observed for samples containing 5 CFUs of E. coli were independent of the 
volume of the liquid sample (Figure 2b). For a given concentration of bacteria (expressed in 
CFU/mL), however, we expect that larger sample volumes will result in more sensitive detection, 
due to the concentration of bacteria on the filter.  
Dirty water, or the presence of other species of bacteria, does not affect the phage-based 
assay. Dirty water, which is often associated with sources of water that may be contaminated, 
does not interfere with the assay (Figure 3a), and the number of PFUs detected from samples of 
drinking water and dirty water containing 50 CFUs of E. coli are statistically indistinguishable. 
We also found that the number of plaques produced from samples of drinking water containing 
50 CFUs of bacteria not targeted by the M13 phage—E. coli BL21 (an F
− E. coli), P. aeruginosa, 
and S. aureus—are statistically indistinguishable from samples containing zero bacteria (Figure 
3b). Samples of drinking water containing a mixture of bacteria (e.g., 50 CFUs of E. coli K12 
and 50 CFUs of E. coli BL21) produce the same number of PFUs as a sample containing only 50 
CFUs of E. coli K12.  
The species-specificity of a bacteriophage reduces the likelihood of false-positive readings; it 
is, however, important to note that a false positive is possible if the excess phage on the filter are 
not properly deactivated with a ferrous ion-containing solution. The need for a sterile laboratory 
environment (for plating and culturing the phage-containing samples) and numerous controls (to 
ensure that the excess phage are inactivated with ferrous ions, and excess ferrous ions are 
inactivated with citrate ions) makes a culture-based assay difficult to implement at the point of  
 
access. An ideal assay would require few experimental steps, no access to a laboratory, and 
produce a visual signal in less time than required for culture. 
A portable, visual readout-based assay has a limit of detection of 50 CFUs of E. coli in one 
liter in 4 hours. While the overlay-based assay surpasses the requirements set by the EPA for a 
coliform test—the ability to detect one CFU of E. coli in 100 mL of water in less than 24 h—a 
solution-based assay, with a visual-readout, would be attractive because there are no approved 
point-of-access assays for bacteria that do not rely on culture of the sample. 
This solution-based assay relies on the collection of the newly produced βgal molecules, 
rather than newly produced phage. A readout based on βgal eliminates the need for washing the 
filter with ferrous ammonium sulfate and sodium citrate because the presence of excess phage 
does not affect the result. Following the incubation of the sample with the phage, we treated the 
filter with a solution that contained lysozyme, which lysed any bacteria present on the filter and 
released their contents, and a substrate for βgal (see Supporting Information). We collected the 
filtrate and monitored the enzymatic reaction for changes in color. 
There are a number of substrates that are converted to a colored product in the presence of 
βgal.
32 We compared three substrates that are listed in methods already approved by the EPA:
1 2-
nitrophenyl β-D-galactopyranoside (ONPG), which yields 2-nitrophenol (ONP, yellow in color); 
chlorophenol red-β-D-galactopyranoside (CPRG), which yields chlorophenol red (CPR, red in 
color); and 4-methylumbelliferyl β-D-galactopyranoside (MUG), which yields 4-
methylumbelliferone (MU, fluorescent).  
Figure 4a shows the visual limits of detection for ONP, CPR, and MU, based on the 
measurement of a series of standard solutions; we also measured the absorbance and 
fluorescence of each solution with a spectrometer to ensure that the calibration trends were linear  
 
(see Supporting Information). The visual limit of detection of CPR (~0.01 mM) is approximately 
20-fold lower than that of ONP (0.2 mM), which is a more commonly used substrate for βgal. 
MU was the most sensitive of the three substrates, with a visual limit of detection of ~0.0003 
mM when excited with a handheld UV lamp or an LED emitting in the UV. LEDs are 
compatible with a portable assay, are easy to use, inexpensive (< $1 per flashlight), and require 
little power (~18 h of continuous light, or over 10,000 samples, on a single lithium battery). 
To determine the limit of detection of the solution-based assay we captured and infected 
between zero and 5000 CFUs of E. coli on the syringe filter, lysed the bacteria in the presence of 
MUG or CPRG, and collected the lysate in 1.5-mL centrifuge tubes. The fluorescent signal (of 
MU) in samples of water, milk, and orange juice containing 50 CFUs of E. coli was observed 
after 3 hours of incubation. To achieve a visible colorimetric result (using CPR) in the same 
period of time required ~1x10
6 CFUs of E. coli.  
Figure 4b shows a 0.2-µm syringe filter before (left) and after (right) it was used to filter 10 
mL of soil-contaminated water. The filtrate from the dirty water did not interfere with the visual 
detection of CPR or MU, whereas the visual detection of ONP was limited by the discoloration 
of the filtrate (Figure 4c). The presence of particulates of soil does not interfere with the 
visualization of MU (Figure 4d). 
Phage-infected E. coli produce a positive result more quickly than coliform E. coli that 
express βgal natively. Detection of natively expressed βgal forms the basis of the culture-based 
assays for coliform bacteria approved by the EPA. The lacZ gene, which encodes βgal, was 
removed from the genome of the E. coli strain (K12 ER2378) used in these proof-of-principle 
studies. To determine if the number (and activity) of βgal molecules present in a sample of 
coliform bacteria could produce a false-positive result in the visual readout-based assay we  
 
compared the activity of βgal in samples containing βgal-expressing E. coli (NCTC 9001, 
collected from urine) to our model organism, E. coli K12 ER2738. 
We repeated the solution-based assay with E. coli NCTC 9001, and monitored the production 
of MU with a fluorescence plate reader. The time required for 50,000 CFUs of NCTC 9001 to 
produce a visible signal of MU was approximately 8 hours, whereas a sample of 50 CFUs of E. 
coli K12 produced a visual signal from MU in less than 4 hours. We conclude that the presence 
of endogenous βgal will not interfere with phage-based amplification and detection. Engineering 
an enzymatic reporter into the phage that is not present in the target bacterium is also a plausible 
strategy to reduce this type of background. 
Conclusion. 
There is presently no convenient or cost-effective method to test samples of liquid for the 
presence of bacteria at a point of interest (e.g., a water source, an assembly line in a food 
processing plant, a container of pooled milk samples, etc). Commercially available kits rely, as 
do most laboratory-based assays, on the overnight culture of the sample. This paper describes an 
alternative assay, based on the species-specific infection of bacteria in a sample with a self-
amplifying system: a bacteriophage. We have detected 50 CFUs of E. coli in a 1-liter sample of 
drinking water in less than 4 hours with a visual-based readout. 
The selectivity of this assay is two-fold, and arises from the specific interactions of phage for 
bacteria, and of enzyme for substrate. Phages are an ideal reagent for diagnostics because, in 
addition to their selectivity, they can be stored dry, and can be engineered to co-express a variety 
of reporter enzymes that produce colored, fluorescent, or electrochemically-active species. There 
are a number of repositories of already sequenced phages,
33 and the procedures for inserting a 
gene of interest into the phage genome are well-established.
25  
 
The sensitivity of this assay arises from two steps of amplification: i) the replication of 
phage, which can amplify in number by a factor of up to 1000, and ii) the catalytic activity of a 
high-turnover-rate enzyme, which is co-expressed with each phage (which can produce an 
additional amplification of ~10
6 per hour for βgal). We can increase the sensitivity of the assay 
by introducing a second round of phage infection and amplification—similar to the approach 
used to prepare overlay plates—but note that this extra step limits the utility of this assay for 
onsite monitoring of liquid samples. There are a number of alternatives that could increase the 
sensitivity of this assay while not decreasing its utility: the use of βgal substrates with lower 
limits of visual detection; an electrochemical or polymerization-based assay whose product is 
more easily detected than a change in color; or phages engineered to co-express multiple copies 
of an enzyme with a high turnover rate. 
Supporting Information. 
A detailed procedure for the culture- and solution-based phage assays; materials and methods 
section; calibration curves of ONP, CPR, and MU. This material is available free of charge via 
the Internet at http://pubs.acs.org. 
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Scheme 1. Schematic of the assay based on bacteriophage amplification. Filtering an aqueous 
sample through a 0.2-µm filter captures bacteria on the surface of the filter. A bacteriophage of 
interest (e.g., M13 filamentous phage, which co-expresses βgal) is introduced to infect the 
bacteria. The phage replicate on the filter and co-express the enzyme of interest during an 
incubation period (generally 60 minutes). After incubation, the newly produced phage is 
quantified with a culture-based assay (an overlay plate), or the newly produced enzyme is 
quantified with a solution-based enzymatic assay.  
 
 
 
 
Figure 1. a) Samples of drinking water, orange juice, skim milk, and dirty water with increasing 
concentrations of CPR (0 µM left, 4 µM to 250 µM in 2-fold increases in concentration). b) 
Photographs of samples of orange juice, dirty water, and skim milk before filtration (i), after 
treatment with base (ii, milk only), and after filtration (iii - iv). c) Average transmittance (at 570 
nm) of the n = 4 samples, before and after filtration, as an indicator of opacity. 
  
 
 
Figure 2. a) Number of PFUs of M13 phage detected with a plaque assay from 10-mL samples 
of drinking water containing known CFUs of E. coli. b) Number of PFUs of M13 phage detected 
for 1, 10, 100 and 1000 mL samples of drinking water containing zero CFUs of E. coli (bottom 
row) and 5 CFUs of E. coli (top row). The gray regions demarcate an interval within one 
standard deviation from the mean obtained for a sample of 100 mL (the volume required for 
EPA-approved tests for coliform bacteria in drinking water). Each point is the average of n = 9 
experiments, and the error bars represent one standard deviation from the mean.  
 
 
 
Figure 3. a) Number of PFUs of M13 phage detected with the plaque assay from samples of 
drinking water and dirty water (containing 5g / 100 mL of soil) containing E. coli. b) Number of 
PFUs of M13 phage detected with a plaque assay from 10 mL samples of drinking water 
containing 50 CFUs of the indicated bacterium. Mixtures containing two species of bacteria 
contained 50 CFUs of each species. Each point is the average of n = 9 experiments, and the error 
bars represent one standard deviation from the mean. 
 
   
 
 
Figure 4. a) Visual detection of 2-nitrophenol (left) and chlorophenol red (middle) obtained with 
a flatbed scanner, or 4-methylumbelliferone (right) obtained from illuminating the samples with  
 
a handheld UV lamp. The concentrations of 2-nitrophenol and chlorophenol red in each row 
decrease by a factor of 2 (from top to bottom); the concentration of 4-methylumbelliferone in 
each row decreases by a factor or 10. b) Syringe filter before (left) and after (right) filtering 10 
mL of dirty water (containing 5 g of soil / 100 mL of water). c) Three samples of liquid passed 
through a 0.2-µm filter: (left) a sample of 1X PBS containing 1 mg/mL of ONPG and no 
bacteria; (middle) a sample of 1X PBS containing 1 mg/mL of ONPG and potting soil, but no 
bacteria; (right) a sample 1X PBS containing 1 mg/mL of ONPG, 5000 phage-infected E. coli, 
and potting soil. The coloration of the middle tube, which contained no bacteria, is due to small 
particulates that passed through the 0.2-µm filter and is not from cleaved ONPG molecules. d) 
Samples of 1X PBS containing 0.1 mg/mL of MUG and potting soil. The sample on the left 
contained 500 phage-infected E. coli, the sample on the right contained no E. coli. 